| 44 |
Weill Cornell Medicine |
Oncology |
Small molecule |
Malic Enzyme 1 (ME1) Inhibitors for Pancreatic and Gastrointestinal Cancers
|
| 43 |
Weill Cornell Medicine |
Oncology |
Small molecule |
Inhibitors of MALT1 for the Treatment of Lymphomas
|
| 42 |
Weill Cornell Medicine |
Oncology |
Small molecule |
6-Ethylthioinosine for the Treatment of Cancers that Overexpress Adenosine Kinase (ADK)
|
| 31 |
Weill Cornell Medicine |
Oncology |
Antibody Conjugated |
Anti-CDCP1 Antibody-Drug Conjugate for the Treatment of Solid Tumors
|
| 30 |
Weill Cornell Medicine |
Oncology |
Antibody |
Anti-ART1 Monoclonal Antibody for Improved Anticancer Immunotherapy
|
| 16 |
Weill Cornell Medicine |
Immunology, Oncology, Ophthalmology |
Small molecule |
Irreversible S1PR2 Antagonists for the Treatment of Inflammation and Fibrosis
|
| 15 |
Weill Cornell Medicine |
Immunology, Oncology |
Protein |
Inflammasome Agonist Proteins for Vaccine and Immunotherapy
|
| 9 |
Weill Cornell Medicine |
Dermatology |
Small molecule |
Soluble Adenylyl Cyclase (sAC) Inhibitors for the Treatment of Psoriasis
|
| 3 |
Weill Cornell Medicine |
Cardiovascular disease, Metabolic disease |
Nucleotide |
A MicroRNA Mimic for the Treatment of Familial Hypercholesterolemia and Atherosclerosis
|
| 2 |
Weill Cornell Medicine |
Musculoskeletal disease, Endocrinology |
Protein |
Targeting the SLIT3 Pathway to Promote Bone Formation
|
